Camp4 Therapeutics Corporation
CAMP
$4.44
$0.040.80%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 18.84% | 50.82% | -46.63% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.84% | 50.82% | -46.63% | -- | -- |
| Cost of Revenue | 4.58% | 0.14% | -16.40% | -3.57% | 10.16% |
| Gross Profit | -2.17% | 4.54% | 14.29% | 11.76% | 5.78% |
| SG&A Expenses | 3.83% | 10.31% | 1.64% | 20.50% | 27.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.36% | 2.92% | -10.64% | 3.23% | 14.71% |
| Operating Income | -2.70% | 0.22% | 8.96% | 2.66% | -2.89% |
| Income Before Tax | -166.39% | -47.44% | -203.37% | -11.98% | -0.09% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -166.39% | -47.44% | -203.37% | -11.98% | -0.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -166.39% | -47.44% | -203.37% | -11.98% | -0.09% |
| EBIT | -2.70% | 0.22% | 8.96% | 2.66% | -2.89% |
| EBITDA | -2.12% | 1.01% | 8.90% | 2.73% | -2.94% |
| EPS Basic | 7.30% | 48.70% | 2.83% | 97.71% | 97.60% |
| Normalized Basic EPS | 7.28% | 48.70% | 2.83% | 97.79% | 97.60% |
| EPS Diluted | 7.30% | 48.70% | 2.83% | 97.71% | 97.60% |
| Normalized Diluted EPS | 7.28% | 48.70% | 2.83% | 97.79% | 97.60% |
| Average Basic Shares Outstanding | 187.35% | 187.42% | 212.23% | 4,793.20% | 4,068.67% |
| Average Diluted Shares Outstanding | 187.35% | 187.42% | 212.23% | 4,793.20% | 4,068.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |